Effective allogeneic natural killer cell therapy for pancreatic adenocarcinoma avails conserved activating receptors and evades HLA I-driven inhibition

Stacey N. Lee(Dalhousie University), Jeanette E. Boudreau(Dalhousie University), Thomas Arnason(Dalhousie University), Riley J. Arseneau(Dalhousie University)
Journal for ImmunoTherapy of Cancer
February 1, 2026
Cited by 1


Related Papers